Patterns of Alcohol Use After Early Liver Transplantation for Alcoholic Hepatitis
Overview
Authors
Affiliations
Background & Aims: Early liver transplantation (LT) for alcoholic hepatitis (AH) is lifesaving but concerns regarding return to harmful alcohol use remain. We sought to identify distinct patterns of alcohol use post-LT to inform pre-LT candidate selection and post-LT addiction care.
Methods: Detailed post-LT alcohol use data was gathered retrospectively from consecutive patients with severe AH at 11 ACCELERATE-AH sites from 2006-2018. Latent class analysis identified longitudinal patterns of alcohol use post-LT. Logistic and Cox regression evaluated associations between patterns of alcohol use with pre-LT variables and post-LT survival. A microsimulation model estimated the effect of selection criteria on overall outcomes.
Results: Of 153 LT recipients, 1-, 3-, and 5-year survival were 95%, 88% and 82%. Of 146 LT recipients surviving to home discharge, 4 distinct longitudinal patterns of post-LT alcohol use were identified: Pattern 1 [abstinent](n = 103; 71%), pattern 2 [late/non-heavy](n = 9; 6.2%), pattern 3 [early/non-heavy](n = 22; 15%), pattern 4 [early/heavy](n = 12; 8.2%). One-year survival was similar among the 4 patterns (100%), but patients with early post-LT alcohol use had lower 5-year survival (62% and 53%) compared to abstinent and late/non-heavy patterns (95% and 100%). Early alcohol use patterns were associated with younger age, multiple prior rehabilitation attempts, and overt encephalopathy. In simulation models, the pattern of post-LT alcohol use changed the average life-expectancy after early LT for AH.
Conclusions: A significant majority of LT recipients for AH maintain longer-term abstinence, but there are distinct patterns of alcohol use associated with higher risk of 3- and 5-year mortality. Pre-LT characteristics are associated with post-LT alcohol use patterns and may inform candidate selection and post-LT addiction care.
Young K, Patel Y, Hoffman B, Peskoe S, Chow S, Erhart K Gastro Hep Adv. 2025; 4(1):100550.
PMID: 39811674 PMC: 11731465. DOI: 10.1016/j.gastha.2024.09.005.
Advances in the management of alcohol-associated liver disease.
Anouti A, Kerr T, Mitchell M, Cotter T Gastroenterol Rep (Oxf). 2024; 12:goae097.
PMID: 39502523 PMC: 11537353. DOI: 10.1093/gastro/goae097.
Diagnosis of Alcohol Use Disorder and Alcohol-Associated Liver Disease.
Witkiewitz K, Fernandez A, Green E, Mellinger J Clin Liver Dis. 2024; 28(4):699-713.
PMID: 39362716 PMC: 11463730. DOI: 10.1016/j.cld.2024.06.009.
Current Management of Patients With Alcohol-Associated Hepatitis.
Lee B Gastroenterol Hepatol (N Y). 2024; 20(7):401-403.
PMID: 39206025 PMC: 11348548.
Impact of alcohol use on liver disease outcomes.
Desalegn H, Diaz L, Rehm J, Arab J Clin Liver Dis (Hoboken). 2024; 23(1):e0192.
PMID: 38860129 PMC: 11164003. DOI: 10.1097/CLD.0000000000000192.